Treatment of childhood disruptive behavior disorders and callous‐unemotional traits: a systematic review and two multilevel meta‐analyses
Journal of Child Psychology and Psychiatry · 2023
DOI: 10.1111/jcpp.13774 ↗At a glance
Systematische Übersicht in Journal of Child Psychology and Psychiatry, 2023. Written by Samantha Perlstein and 3 co-authors. Institution: Department of Psychology, University of Pennsylvania, Philadelphia, PA, USA. Major MEDLINE topics: Conduct Disorder, Problem Behavior. Cited 87 times so far (Crossref); 81 references. The full text is freely available in PubMed Central. Funded by: NIMH NIH HHS, National Institute of Mental Health.
Abstract (original language)
Background
Children with callous‐unemotional (CU) traits are at high lifetime risk of antisocial behavior. It is unknown if treatments for disruptive behavior disorders are as effective for children with CU traits (DBD+CU) as those without (DBD‐only), nor if treatments directly reduce CU traits. Separate multilevel meta‐analyses were conducted to compare treatment effects on DBD symptoms for DBD+CU versus DBD‐only children and evaluate direct treatment‐related reductions in CU traits, as well as to examine moderating factors for both questions.
Methods
We systematically searched PsycINFO, PubMed, Cochran Library (Trials), EMBASE, MEDLINE, APA PsycNet, Scopus, and Web of Science. Eligible studies were randomized controlled trials, controlled trials, and uncontrolled studies evaluating child‐focused, parenting‐focused, pharmacological, family‐focused, or multimodal treatments.
Results
Sixty studies with 9,405 participants were included ( M age = 10.04, SD age = 3.89 years, 25.09% female, 44.10% racial/ethnic minority). First, treatment was associated with similar reductions in DBD symptoms for DBD+CU ( SMD = 1.08, 95% CI = 0.45, 1.72) and DBD‐only ( SMD = 1.01, 95% CI = 0.38, 1.64). However, DBD+CU started ( SMD = 1.18, 95% CI = 0.57, 1.80) and ended ( SMD = 0.73, p < .001; 95% CI = 0.43, 1.04) treatment with more DBD symptoms. Second, although there was no overall direct effect of treatment on CU traits ( SMD = .09, 95% CI = −0.02, 0.20), there were moderating factors. Significant treatment‐related reductions in CU traits were found for studies testing parenting‐focused components ( SMD = 0.21, 95% CI = 0.06, 0.35), using parent‐reported measures ( SMD = 0.16, 95% CI = 0.04, 0.28), rated as higher quality ( SMD = 0.26, 95% CI = 0.13, 0.39), conducted outside the United States ( SMD = 0.19, 95% CI = 0.05, 0.32), and with less than half the sample from a racial/ethnic minority group ( SMD = 0.15, 95% CI = 0.002, 0.30).
Conclusions
DBD+CU children improve with treatment, but their greater DBD symptom severity requires specialized treatment modules that could be implemented alongside parenting programs. Conclusions are tempered by heterogeneity across studies and scant evidence from randomized controlled trials.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Psychology, University of Pennsylvania, Philadelphia, PA, USA.
ORCID profiles: Samantha Perlstein, Rebecca Waller
Funding
- NIMH NIH HHS
- National Institute of Mental Health
Cite
APA
Perlstein, S., Fair, M., Hong, E., & Waller, R. (2023). Treatment of childhood disruptive behavior disorders and callous‐unemotional traits: a systematic review and two multilevel meta‐analyses. Journal of Child Psychology and Psychiatry. https://doi.org/10.1111/jcpp.13774
Vancouver
Perlstein S, Fair M, Hong E, Waller R. Treatment of childhood disruptive behavior disorders and callous‐unemotional traits: a systematic review and two multilevel meta‐analyses. Journal of Child Psychology and Psychiatry. 2023. doi:10.1111/jcpp.13774
BibTeX
@article{Perlstein2023,
author = {Perlstein, Samantha and Fair, Maddy and Hong, Emily and Waller, Rebecca},
title = {Treatment of childhood disruptive behavior disorders and callous‐unemotional traits: a systematic review and two multilevel meta‐analyses},
journal = {Journal of Child Psychology and Psychiatry},
year = {2023},
doi = {10.1111/jcpp.13774}
}
EUVIMED